FMP
Imunon, Inc.
CLSN
NASDAQ
Inactive Equity
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
1.95 USD
-0.013400078 (-0.688%)
Historical Prices
From:
To:
We are unable to load the chart at this time.
About
Description
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.
CIK
0000749647
ISIN
US15117N6022
CUSIP
15117N602
Address
997 Lenox Dr Ste 100
Phone
16098969100
Country
US
Employee
29
IPO Date
Oct 27, 1993
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
CLSN Financial Summary
CIK
0000749647
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
15117N602
ISIN
US15117N6022
Country
US
Price
1.95
Beta
2.26
Volume Avg.
0
Market Cap
14.47M
Shares
-
52-Week
-
DCF
5.57
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.49
P/B
-
Website
https://celsion.com
Upgrades and Downgrades
We are unable to load this data!
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest CLSN News
It looks like there's no news available.
